Year archive

ROQUEFORT THERAPEUTICS PLC — 2022 filings

All 45 regulatory filings released by ROQUEFORT THERAPEUTICS PLC (ROQ) in 2022, sourced directly from the official regulator.

45 Filings

2022 Period

2022 filings (45)

Filing	Released	Lang
Presentation of Midkine Oligonucleotide Program Investor Presentation	2022-12-05	English
Resignation of Auditor Audit Report / Information FY 2022	2022-12-01	English
Midkine Antibody Program - Festival of Biologics Regulatory Filings	2022-10-25	English
ROQ Presents Study Results at the ESGCT Conference Regulatory Filings	2022-10-11	English
Director/PDMR Shareholding Director's Dealing	2022-09-28	English
Director/PDMR Shareholding Director's Dealing	2022-09-26	English
Interim Results to 30 June 2022 Interim / Quarterly Report H1 2022	2022-09-23	English
Investor Presentation Investor Presentation	2022-09-16	English
Board and Management Appointments Board/Management Information	2022-09-16	English
Acquisition Completion, Admission & Voting Rights Regulatory Filings	2022-09-16	English
Roquefort Therapeutics plc - Single prospectus Regulatory Filings	2022-09-15	English
Notice of Admission Share Issue/Capital Change	2022-09-15	English
Publication of Prospectus Regulatory Filings	2022-09-13	English
Pre-clinical Program & Transaction Update Regulatory Filings	2022-08-11	English
Appointment of Joint Broker Board/Management Information	2022-07-20	English
Commencement of Trading on US OTCQB Venture Market Share Issue/Capital Change	2022-07-15	English
Director/PDMR Shareholding Director's Dealing	2022-07-04	English
Director/PDMR Shareholding Director's Dealing	2022-06-30	English
Result of AGM AGM Information	2022-06-30	English
Update on Acquisition of Oncogeni and Placing M&A Activity	2022-06-23	English
Issue of Warrants Director's Dealing	2022-06-22	English
Investor Presentation Report Publication Announcement	2022-06-22	English
Second Price Monitoring Extn Regulatory Filings	2022-06-22	English
Price Monitoring Extension Regulatory Filings	2022-06-22	English
Proposed Acquisition of Oncogeni Limited & Placing Regulatory Filings	2022-06-22	English
Notice of AGM - Correction AGM Information	2022-06-13	English
Pre-clinical Update Regulatory Filings	2022-06-07	English
Notice of AGM AGM Information	2022-06-07	English
Annual Report & Financial Statements Annual Report FY 2021	2022-05-11	English
Non-Executive Director Appointment Board/Management Information	2022-04-20	English
Board Appointment Board/Management Information	2022-04-05	English
Holding(s) in Company Major Shareholding Notification	2022-03-22	English
Investor Presentation Report Publication Announcement	2022-03-21	English
Patent Filed – New Drug Class Targeting Midkine Regulatory Filings	2022-03-21	English
Holding(s) in Company Major Shareholding Notification	2022-03-08	English
Appointment of Strategic & Scientific Advisor Regulatory Filings	2022-02-14	English
Holding(s) in Company Director's Dealing	2022-02-08	English
Holding(s) in Company Major Shareholding Notification	2022-01-28	English
Director/PDMR Shareholding Director's Dealing	2022-01-19	English
Holding(s) in Company Major Shareholding Notification	2022-01-19	English
Price Monitoring Extension Regulatory Filings	2022-01-18	English
Holding(s) in Company Major Shareholding Notification	2022-01-18	English
Holding(s) in Company Major Shareholding Notification	2022-01-17	English
Pre-clinical Update Regulatory Filings	2022-01-17	English
Publication of New Research Report Publication Announcement	2022-01-10	English